Literature DB >> 9199190

Cloning and characterization of the 5'-flanking region of the human dopamine D4 receptor gene.

S Kamakura1, A Iwaki, M Matsumoto, Y Fukumaki.   

Abstract

Dopamine D4 receptor (DRD4) has received attention in terms of pathogenesis of schizophrenia and association with human personalities. We isolated the human DRD4 gene containing the 5'-flanking region and determined its sequence. Analysis of the DRD4 transcripts by 5'-RACE (5'-rapid amplification of cDNA ends) revealed a region of the transcription initiation located between -501 and -436 relative to the first nucleotide of the initiation codon. There is a CpG island spanning from -900 to +500 but no TATA or CAAT boxes in the 5'-flanking region. Functional analysis of the 5'-flanking region of the DRD4 gene by a transient expression method revealed the presence of a negative modulator between -770 and -679. The region between -591 and -123 gave the highest transcriptional activity in IMR32 (neuroblastoma) and Y-79 (retinoblastoma) cells but not in HeLa cells, suggesting that this housekeeping gene-like promoter regulates the cell-type specific gene expression.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9199190     DOI: 10.1006/bbrc.1997.6770

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  9 in total

1.  Validation of single nucleotide polymorphism quantification in pooled DNA samples with SNaPIT. A glycosylase-mediated methods for polymorphism detection method.

Authors:  Sarah Curran; Linzy Hill; Geraldine O'Grady; Dragana Turic; Philip Asherson; Eric Taylor; Pak Sham; Ian Craig; Pat Vaughan
Journal:  Mol Biotechnol       Date:  2002-11       Impact factor: 2.695

Review 2.  The dopamine D4 receptor: biochemical and signalling properties.

Authors:  Pieter Rondou; Guy Haegeman; Kathleen Van Craenenbroeck
Journal:  Cell Mol Life Sci       Date:  2010-02-18       Impact factor: 9.261

3.  Associations between DRDs and schizophrenia in a Korean population: multi-stage association analyses.

Authors:  Kyu Young Lee; Eun-Jeong Joo; Yong Ick Ji; Duk-Hwan Kim; Joo Bae Park; In-Won Chung; Sang Ick Lee; Yeon Ho Joo; Yong Min Ahn; Joo Yun Song; Yong Sik Kim
Journal:  Exp Mol Med       Date:  2011-01-31       Impact factor: 8.718

4.  Polymorphisms in human dopamine D2 receptor gene affect gene expression, splicing, and neuronal activity during working memory.

Authors:  Ying Zhang; Alessandro Bertolino; Leonardo Fazio; Giuseppe Blasi; Antonio Rampino; Raffaella Romano; Mei-Ling T Lee; Tao Xiao; Audrey Papp; Danxin Wang; Wolfgang Sadée
Journal:  Proc Natl Acad Sci U S A       Date:  2007-12-11       Impact factor: 11.205

5.  Dopamine D4 receptor gene associated with fairness preference in ultimatum game.

Authors:  Songfa Zhong; Salomon Israel; Idan Shalev; Hong Xue; Richard P Ebstein; Soo Hong Chew
Journal:  PLoS One       Date:  2010-11-03       Impact factor: 3.240

6.  An evolutionary conserved region (ECR) in the human dopamine receptor D4 gene supports reporter gene expression in primary cultures derived from the rat cortex.

Authors:  Ursula M Paredes; Vivien J Bubb; Kate Haddley; Gabriele A Macho; John P Quinn
Journal:  BMC Neurosci       Date:  2011-05-20       Impact factor: 3.288

7.  The polymorphic nature of the human dopamine D4 receptor gene: a comparative analysis of known variants and a novel 27 bp deletion in the promoter region.

Authors:  E Szantai; R Szmola; M Sasvari-Szekely; A Guttman; Z Ronai
Journal:  BMC Genet       Date:  2005-06-28       Impact factor: 2.797

8.  No direct effect of the -521 C/T polymorphism in the human dopamine D4 receptor gene promoter on transcriptional activity.

Authors:  Eva Kereszturi; Orsolya Kiraly; Csaba Barta; Noemi Molnar; Maria Sasvari-Szekely; Zsolt Csapo
Journal:  BMC Mol Biol       Date:  2006-05-24       Impact factor: 2.946

9.  Data describing the effect of DRD4 promoter polymorphisms on promoter activity.

Authors:  Shoin Tei; Hiroaki Mitsuhashi; Shoichi Ishiura
Journal:  Data Brief       Date:  2016-04-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.